Targeted case finding for chronic obstructive pulmonary disease versus routine practice in primary care (TargetCOPD): a cluster-randomised controlled trial.

[1]  Elizabeth M. Webber,et al.  Screening for Chronic Obstructive Pulmonary Disease: Evidence Report and Systematic Review for the US Preventive Services Task Force. , 2016, Journal of the American Medical Association (JAMA).

[2]  P. Adab,et al.  Effectiveness of case finding strategies for COPD in primary care , 2015 .

[3]  D. Lambrelli,et al.  Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013 , 2015, International journal of chronic obstructive pulmonary disease.

[4]  R. Riley,et al.  Predicting risk of COPD in primary care: development and validation of a clinical risk score , 2015, BMJ Open Respiratory Research.

[5]  J. Stocks,et al.  Use of forced vital capacity and forced expiratory volume in 1 second quality criteria for determining a valid test , 2014, European Respiratory Journal.

[6]  B. Yawn,et al.  The impact of screening tools on diagnosis of chronic obstructive pulmonary disease in primary care. , 2014, American journal of preventive medicine.

[7]  D. Fitzmaurice,et al.  TargetCOPD: a pragmatic randomised controlled trial of targeted case finding for COPD versus routine practice in primary care: protocol , 2014, BMC Pulmonary Medicine.

[8]  Kayleigh Kew,et al.  Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis. , 2014, Cochrane Database of Systematic Reviews.

[9]  P. Frith,et al.  Self management for patients with chronic obstructive pulmonary disease. , 2014, The Cochrane database of systematic reviews.

[10]  H. Tange,et al.  Early detection of COPD in general practice: patient or practice managed? A randomised controlled trial of two strategies in different socioeconomic environments , 2013, Primary Care Respiratory Journal: Journal of the General Practice Airways Group.

[11]  S. Stanojevic,et al.  Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations , 2012, European Respiratory Journal.

[12]  D. Fitzmaurice,et al.  Case finding for chronic obstructive pulmonary disease: a model for optimising a targeted approach , 2010, Thorax.

[13]  Kerenza Hood,et al.  Balance algorithm for cluster randomized trials , 2008, BMC medical research methodology.

[14]  J. Vestbo,et al.  COPD-related morbidity and mortality after smoking cessation: status of the evidence , 2008, European Respiratory Journal.

[15]  J Stocks,et al.  Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction , 2008, Thorax.

[16]  D. Mannino,et al.  International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study , 2007, The Lancet.

[17]  D. Mannino,et al.  Global burden of COPD: systematic review and meta-analysis , 2006, European Respiratory Journal.

[18]  R. Wood‐Baker,et al.  Influenza vaccine for patients with chronic obstructive pulmonary disease. , 2006, The Cochrane database of systematic reviews.

[19]  J. Hankinson,et al.  Standardisation of spirometry , 2005, European Respiratory Journal.

[20]  G. Zou,et al.  A modified poisson regression approach to prospective studies with binary data. , 2004, American journal of epidemiology.

[21]  S. Hurd,et al.  Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update , 2003, European Respiratory Journal.

[22]  F. Ram,et al.  Short-acting beta2-agonists for stable chronic obstructive pulmonary disease , 2002 .

[23]  T L Petty,et al.  Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. , 2000, Archives of internal medicine.

[24]  C. van Weel,et al.  The economic effects of screening for obstructive airway disease: an economic analysis of the DIMCA program. , 2000, Preventive medicine.

[25]  C. van Weel,et al.  Active detection of chronic obstructive pulmonary disease and asthma in the general population. Results and economic consequences of the DIMCA program. , 1998, American journal of respiratory and critical care medicine.

[26]  P. Adab,et al.  Case finding for chronic obstructive pulmonary disease in primary care: a pilot randomised controlled trial. , 2013, The British journal of general practice : the journal of the Royal College of General Practitioners.

[27]  J. Hankinson,et al.  MULTI-ETHNIC REFERENCE VALUES FOR SPIROMETRY FOR THE 3–95 YEAR AGE RANGE: THE GLOBAL LUNG FUNCTION , 2013 .

[28]  M. Ashworth,et al.  Quality and Outcomes Framework: smoke and mirrors? , 2010, Quality in primary care.

[29]  J. Steurer,et al.  Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. , 2009, The Cochrane database of systematic reviews.

[30]  P. Rouger.  [The White Book]. , 2008, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

[31]  C. Weel,et al.  Active Detection of Chronic Obstructive Pulmonary Disease and Asthma in the General Population Results and Economic Consequences of the DIMCA Program GUIDO van den BOOM, CONSTANT P. van SCHAYCK, MAUREEN P. M. H. RUTTEN-van MÖLKEN, , 1998 .